Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

337 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Active, not recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

NCT07036523

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Florida Gainesville, Florida, United States
  • Renstar Medical Research Ocala, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 46 locations
View Trial Details
Active, not recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

NCT06238622

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 373 locations
View Trial Details
Active, not recruiting

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

NCT02407431

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Jody McCullough Hershey, Pennsylvania, United States
  • Anuradha Paranjape Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Active, not recruiting

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

NCT05389215

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Associates, PA Mesa, Arizona, United States
  • Dignity Health Norton Thoracic Institute Phoenix, Arizona, United States
  • The University of California San Francisco San Francisco, California, United States
  • Loyola University Medical Center (LUMC) Maywood, Illinois, United States
View all 30 locations
View Trial Details
Active, not recruiting

A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

NCT06736990

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Keck School of Medicine at USC Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Y & L Advance Health Care, Inc. d/b/a Elite Clinical Research Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View all 54 locations
View Trial Details
Active, not recruiting

MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06132256

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • Wallace Street Specialist Centre Brisbane, Queensland, Australia
  • Mater Misericordiae Ltd South Brisbane, Queensland, Australia
View all 78 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

NCT06003426

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • Local Institution - 0189 Birmingham, Alabama, United States
  • Local Institution - 0361 Phoenix, Arizona, United States
  • Local Institution - 0396 La Jolla, California, United States
  • Local Institution - 0193 Los Angeles, California, United States
View all 390 locations
View Trial Details

Related conditions